Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | INSM | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Insmed Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 322.14 | 832.15 | 149.49 | ||
| High | 325.04 | 837.54 | 149.83 | ||
| Low | 317.80 | 822.60 | 145.36 | ||
| Latest | 322.28 | 834.55 | 148.43 | ||
| Change | -0.70 | +1.39 | -0.12 | ||
| % Change | -0.22% | +0.17% | -0.08% | ||
| Volume | 1,582,100 | 197,000 | 1,496,100 | ||
| 20-Day Average Volume | 1,579,060 | 388,540 | 2,349,570 | ||
| Previous Close | 322.98 | 833.16 | 148.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 347.62 | 828.94 | 156.23 | ||
| 20-Day Raw Stochastic | 7.58% | 53.05% | 15.27% | ||
| 20-Day Relative Strength | 31.39 | 49.90 | 35.90 | ||
| Weighted Alpha | +6.22 | +34.34 | +57.30 | ||
| Today's Opinion | 88% Sell | 32% Buy | 8% Sell | ||
| Previous Opinion | 72% Sell | 32% Buy | 8% Sell | ||
| Last Month's Opinion | 40% Sell | 24% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.43% since 02/04/26 | -1.92% since 02/04/26 | -2.63% since 02/04/26 | ||
| Low | 317.80 on 02/11/26 | 810.74 on 02/06/26 | 145.36 on 02/11/26 | ||
| High | 350.49 on 02/05/26 | 861.72 on 02/05/26 | 156.52 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | -19.08% since 01/09/26 | +5.84% since 01/09/26 | -15.65% since 01/09/26 | ||
| Low | 317.80 on 02/11/26 | 770.67 on 01/12/26 | 145.36 on 02/11/26 | ||
| High | 378.61 on 01/12/26 | 881.89 on 01/27/26 | 175.12 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | -28.69% since 11/11/25 | -6.19% since 11/11/25 | -23.37% since 11/11/25 | ||
| Low | 317.80 on 02/11/26 | 770.67 on 01/12/26 | 145.36 on 02/11/26 | ||
| High | 479.79 on 12/03/25 | 934.62 on 12/03/25 | 212.75 on 12/02/25 | ||
| 6-Month | |||||
| %Chg | -25.91% since 08/11/25 | +30.62% since 08/11/25 | +31.48% since 08/11/25 | ||
| Low | 317.80 on 02/11/26 | 636.10 on 08/12/25 | 112.48 on 08/12/25 | ||
| High | 495.55 on 10/20/25 | 934.62 on 12/03/25 | 212.75 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,670,176 | 51,558,432 | 31,681,704 | ||
| Shares Outstanding, K | 132,114 | 61,883 | 213,273 | ||
| Annual Sales | 2,248,240,000 | 2,252,040,000 | 363,710,000 | ||
| Annual Net Income | -278,160,000 | 833,040,000 | -913,770,000 | ||
| Last Quarter Sales | 1,249,030,000 | 1,151,340,000 | 142,340,000 | ||
| Last Quarter Net Income | 251,080,000 | 344,260,000 | -370,020,000 | ||
| 60-Month Beta | 0.35 | 0.37 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.90 on 10/30/25 | 5.18 on 10/30/25 | -1.75 on 10/30/25 | ||
| Latest Earnings Date | 02/12/26 | 02/26/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 1,391.30 | 63.32 | 0.00 | ||